Alexandre Maurel

Alexandre Maurel has a diverse work experience in various roles and industries. Alexandre is currently working as a Product Manager at Posos, where they provide personalized prescription support using artificial intelligence and medical knowledge.

Prior to this, Alexandre worked as a Business Analyst in the HealthTech sector at Agoranov from September 2020 to October 2021.

Alexandre also served as the Right Hand CEO at Zeta from July 2019 to January 2020, where they designed a clinical trial to alleviate tinnitus through a sound therapy.

Before that, Alexandre worked as a Research Scholar at NTT from January 2018 to August 2018, and as a Vulcanus in Japan Trainee at the EU-Japan Centre for Industrial Cooperation from September 2017 to August 2018.

Alexandre also gained experience as a Visiting Research Scholar at Université de Genève in 2017, where they worked on implementing behavioral studies and visual stimuli presentations for small primates.

Additionally, Alexandre worked as an R&D Intern at Total from September 2016 to December 2016, studying emulsion breaking for biomolecule production.

Overall, Alexandre Maurel has accumulated valuable experience in product management, business analysis, clinical trial design, and research in various industries.

Alexandre Maurel has a diverse education history. From 2011 to 2014, they attended Lycée Blaise Pascal, where they completed Preparatory Classes in Physics & Chemistry. In 2014, they started their studies at ESPCI Paris - PSL where they obtained a Diplôme d'ingénieur - Master's degree in Biotechnology. Continuing their educational journey, they pursued further studies at The Naganuma School in 2017, focusing on Japanese Language and Literature and passing the Japanese language proficiency test - N4 (CEFR A2/B1). In 2018, they simultaneously enrolled in three institutions. Alexandre attended HEC Paris where they pursued a Master of Science (M.Sc.) X-HEC Entrepreneurs program in Entrepreneuriat / études entrepreneuriales. Additionally, they pursued a Master 2 (M2) in Innovation Technology and Entrepreneurship at École Polytechnique and a Master 2 (M2) in the Biomedical Engineering Master's Program (BME-ParisTech) at Université Paris Cité.